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Objectives: Studies have shown that the use of psychotropic medications such as 
sedative hypnotics have a significant association with risk of falls in older adults. 
However, very few studies have assessed the association with poor sleep, medications 
used to improve sleep, and the combined effect of these variables on the risk of falls. 
The objectives were: 1) to determine the prevalence of sleep problems, use of sleep 
medications and falls and 2) to evaluate the association between sleep problems, sleep 
medications, and falls in adults aged 65 or older. MethOds: The study population 
comprised a nationally representative sample of non-institutionalized adults aged 
65 years or older participating in the 2010 Health and Retirement Study. Prevalence 
of sleep problems, sleep medication use and falls was calculated. Logistic regression 
modeling was used to examine the effect of sleep problems, sleep medications, and 
both on the risk of falls after controlling for covariates. Statistical analysis was per-
formed using SAS 9.4 statistical software. Results: In 9,937 community-dwelling 
older adults, 36% had fallen in the past two years. 71% reported sleep problems and 
21% reported taking medications or other treatments to help sleep. Older adults who 
do not have sleep problems and take sleep medications (OR= 1.50, 95%CI= 1.10-2.03) 
and those who do have sleep problems and take sleep medications (OR= 1.28, 95%CI= 
1.07-1.54) have a significant risk of falls, compared to older adults who do not have 
sleep problems and do not take sleep medications. cOnclusiOns: Sleep problems, 
use of sleep medications, and occurrence of falls are common among older adults. 
Consistent with previous literature, sleep medication use predicted falls. However, 
those with sleep problems not taking sleep medication did not have significant risk 
of falls as has been previously reported. Health care professionals should consider 
medication-associated risk when treating sleep problems in older adults.
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Objectives: This 2-year long prospective observational study was undertaken 
to characterize the most common medications involved in causing Adverse Drug 
Reactions (ADRs) in the Indian elderly inpatients. MethOds: The records of 1510 
inpatients aged 60 years or above, either sex, were assessed using subjective and 
objective parameters to identify ADRs. Results: Of the total 1510 patient records 
evaluated, 228 ADRs were noted in 197 patients. The prevalence of ADRs in Indian 
elderly inpatients was found to be 13%. Type A ADRs accounted for 85% of the total 
ADRs. The most frequently occurring ADR was hypotension. The 3 most frequently 
involved drug classes in ADRs were Cardiovascular (CVS) drugs (70%), followed by 
Blood and blood forming organs (12%) and Anti-infectives (6.5%). Within the CVS 
drugs, antihypertensives, diuretics and lipid modifying drugs were the causative 
agents. cOnclusiOns: Cardiovascular agents were the most commonly involved 
drugs associated with ADRs in the elderly inpatients. In view of the fact that these 
drugs are well established in clinical practice, prevention of the CV illnesses seems 
to be the only route to minimize the adverse drug reactions for the Indian popula-
tion.
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Objectives: The relationship between medically assisted reproduction (MAR) use 
and the risk of major congenital malformations (MCM) is controversial. Multiplicity 
is a recognized adverse effect of MAR; nevertheless, there is no consensus on the 
incremental risk. Our meta-analysis summarizes the literature on fertility treat-
ments and risks for the newborn, explains discrepancies between studies, and 
identifies the gaps in knowledge for future research. MethOds: We carried out a 
systematic review to identify published papers between 1966 and 2012 in Medline, 
Embase and Cochrane Central Register of Controlled Trials. We included observa-
tional studies and randomized clinical trials related to the risk of multiplicity or 
MCM conceived following ovarian stimulation (OS) alone, intrauterine insemination 
(IUI) and in-vitro fertilization (IVF) with related procedures compared to sponta-
neously conceived infants or infants conceived using other MAR. Results: We 
identified 238 eligible studies. Among them, 186 reported data on IVF, 37 reported 
data on OS used alone and 21 on IUI use. Compared to natural conception, OS used 
alone was associated with a greatly increased risk of multiplicity (RR 11.07, 95% CI 
6.94-17.67), major congenital anomalies of nervous system (RR 1.88, 95% CI 1.20 
-2.96) and major musculoskeletal malformations (RR 1.38, 95% CI 1.06-1.79). The 
risk of multiplicity further decrease and the risk of major musculoskeletal mal-
formations increase when data were restricted to clomiphene citrate (the first line 
OS). Compared to natural conception, the use of IUI was associated with greatly 
increased risk of multiplicity (RR 10.16, 95% CI 7.35-14.06) and major musculoskel-
etal malformations (RR 1.66, 95% CI 1.26-2.18). cOnclusiOns: A limited number 
of observational studies focused on the risk of multiplicity and MCM following OS 
alone and IUI compared the data on IVF use. Results suggest that overall OS used 
with or without IUI increases the risk of multiple birth and some types of MCM.
PIH4
rIsk of falls and fraCtures assoCIated WItH antICHolInergIC 
MedICatIon use In tHe elderly
Chatterjee S1, Carnahan R.M.2, Holmes H.M.3, Chen H.1, Johnson M.L.1, Aparasu R.R.1
1University of Houston, Houston, TX, USA, 2University of Iowa, Iowa city, IA, USA, 3University of 
Texas MD Andersen Cancer Center, Houston, TX, USA
statistically significantly higher rates of therapy addition compared to the non-IPH 
group (2.1% vs. 0.9%; p< 0.0001), switches in therapy (2.3% vs. 0.6%; p< 0.0001) and 
treatment discontinuations (3.9% and 3.2%; p= 0.001). There were multiple statistically 
significant differences between the IPH and non-IPH groups across several antidia-
betic drug classes regarding therapy addition, switch or discontinuation. For example, 
IPH patients were 12.5 times more likely to add basal insulin compared to non-IPH 
patients (95% CI, 3.7 - 42.4; p< 0.0001). cOnclusiOns: Inpatient admission of patients 
with T2DM was associated with more frequent treatment modifications to their pre-
admission treatment regimen compared to a matched cohort of patients without 
inpatient admissions. An inpatient admission represents an opportunity to modify 
pre-admission diabetic treatment regimens. Future studies are needed to determine 
if such modifications are associated with improvements in patient outcomes.
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Objectives: Community-acquired pneumonia (CAP) represents a considerable 
burden in senior adults in Russia. In adults > 18 years, the incidence is ~280 per 
100K, with > 1% of treated cases resulting in death. The risk of CAP increases with 
increasing age and comorbidities. We assessed resource use and outcomes of CAP in 
Russia to characterize disease burden in Russian adults. MethOds: We conducted a 
retrospective chart review in a central Russian region of Tver for samples of 500 and 
400 patients treated in inpatient and outpatient settings respectively. All patients 
were 50 years of age and older and were not transferred from a hospital or previ-
ously hospitalized in the past 2 weeks. Data were collected regarding age, gender, 
comorbidities, referral patterns, outcomes, resource use, employment status, and 
productivity loss. Results: Among inpatient CAP episodes the mean age was 65.9 
years and 55.4% were male. Most of the hospital admissions were referred by outpa-
tient physician (63.4%), 25.4% were admitted by ambulance and 11.2% self-referred. 
Among outpatient cases the mean age was 65.5 years and 52% were male. Based on 
comorbidities, 75.0% of inpatient and 68.8% of outpatient cases were at moderate/
high risk of pneumonia. The overall length of stay among inpatient cases was 13.6 
days. Mean length of stay was similar across age groups and by risk categories. 
Outpatient cases received an average of 5 procedures, including one X-ray per case, 
and an average 8.4 days of antibiotic therapy. Employed patients below retirement 
age comprise 12.8% and 18.3% of the inpatient and outpatient cases, respectively, 
and days lost from work per patient of working age was 8.0 (inpatient) and 7.0 
(outpatient). cOnclusiOns: CAP is a significant cause of health care utilization in 
adults in Russia. Most CAP patients have chronic comorbidities. Resource utilization 
was similar across age and risk groups.
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Objectives: To analyze the feasibility of a collaborative evidence-based consensus-
driven pathway in rheumatoid arthritis (RA). Unsustainable cost trends in health 
care have been the focus of much debate. RA has been a particular target of these 
concerns due to its chronic nature, arsenal of expensive therapeutics, variability in 
patterns of care, care coordination issues and often absent objective determinants 
of disease activity and treatment responsiveness. Pathway programs have been sug-
gested as a means to decrease treatment variability thereby improving quality and 
cost. MethOds: CareFirst BlueCross BlueShield and Cardinal Health collaborated 
with rheumatologists in the CareFirst network to develop a payer-sponsored RA 
pathway program. Participation was voluntary but reimbursement enhancements 
were offered to mitigate cost of provider adoption and compliance. Results: 80 
physicians from 37 CareFirst community network practices signed participation 
agreements. A steering committee of 12 physicians created the pathway with the 
following unique elements: obligatory use of a real-time decision-support and 
data-capture tool; requirement for a clinical disease activity index (CDAI) at each 
physician visit; use of disease-modifying antirheumatic drugs as first-line treat-
ment for at least 12 weeks before use of biologic agents; and a requirement that 
dose, schedule, and adjustments for biologic agents follow package label prescribing 
guidelines. A total of 1800 unique RA patients entered the program. CDAI capture 
through the decision support tool exceeded 70% of visits. DMARD rule compliance 
resulted in an 8% reduction in overall biologic agent use. Claims-validated com-
pliance with initial infused biologic agent dose and schedule by label increased 
from 40% to 53%. Pathway adherence was without a consequent increase in CDAI 
scores. cOnclusiOns: High-level pathway program adoption suggests feasibility of 
this approach. Label-based prescribing of DMARD and biologic agents was not asso-
ciated with higher CDAI scores, confirming that evidenced-based algorithms do not 
jeopardize patient outcomes. Opportunity exists to improve biologic use compliance.
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